ArticleOncotarget2016

Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.

Vito Alessandro Lasorsa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.